tiprankstipranks
Advertisement
Advertisement

SG:42T Stock Latest News

Trendlines Portfolio Scores U.S. Deals, Patents and EU Project as Fundraising Accelerates
Company AnnouncementsTrendlines Portfolio Scores U.S. Deals, Patents and EU Project as Fundraising Accelerates
11h ago
42T
Trendlines’ ElastiMed Secures Exclusive U.S. Distribution Deal for Wearable Compression Device
PremiumCompany Announcements
Trendlines’ ElastiMed Secures Exclusive U.S. Distribution Deal for Wearable Compression Device
17d ago
42T
Trendlines Portfolio Firm NICE Surgical Wins U.S. Patent for Colorectal Stapling Device
PremiumCompany Announcements
Trendlines Portfolio Firm NICE Surgical Wins U.S. Patent for Colorectal Stapling Device
28d ago
42T
Trendlines Highlights Portfolio Milestones and Previews H1 2026 Results
PremiumCompany Announcements
Trendlines Highlights Portfolio Milestones and Previews H1 2026 Results
29d ago
42T
Trendlines taps related-party co-investment to bolster ProArc funding
PremiumCompany Announcements
Trendlines taps related-party co-investment to bolster ProArc funding
1M ago
42T
Trendlines Updates Portfolio Milestones and Equity Incentive Moves
PremiumCompany AnnouncementsTrendlines Updates Portfolio Milestones and Equity Incentive Moves
2M ago
42T
Trendlines’ Phytolon Raises US$23.6 Million to Scale Natural Food Colors After FDA Nod
Premium
Company Announcements
Trendlines’ Phytolon Raises US$23.6 Million to Scale Natural Food Colors After FDA Nod
2M ago
42T
Trendlines shareholders back board, auditors and tighter share-issue mandate at AGM
Premium
Company Announcements
Trendlines shareholders back board, auditors and tighter share-issue mandate at AGM
3M ago
42T
Trendlines secures co-investments from controlling shareholder’s related entities for key portfolio firms
PremiumCompany Announcements
Trendlines secures co-investments from controlling shareholder’s related entities for key portfolio firms
3M ago
42T
Trendlines-Backed Vensica Wins FDA Go-Ahead for Phase 2 Needle-Free Bladder Therapy
PremiumCompany Announcements
Trendlines-Backed Vensica Wins FDA Go-Ahead for Phase 2 Needle-Free Bladder Therapy
3M ago
42T
Trendlines Highlights AGM Outcomes and Portfolio Breakthroughs in Food and Agri-Tech
PremiumCompany Announcements
Trendlines Highlights AGM Outcomes and Portfolio Breakthroughs in Food and Agri-Tech
3M ago
42T
Trendlines’ Celleste Bio Debuts Milk Chocolate Made with Cell-Cultured Cocoa Butter
PremiumCompany Announcements
Trendlines’ Celleste Bio Debuts Milk Chocolate Made with Cell-Cultured Cocoa Butter
3M ago
42T
Trendlines Returns to Profit as Portfolio Notches Regulatory and Industry Wins
PremiumCompany AnnouncementsTrendlines Returns to Profit as Portfolio Notches Regulatory and Industry Wins
5M ago
42T
Trendlines Maintains Operations Amid Escalating Security Tensions in Israel
Premium
Company Announcements
Trendlines Maintains Operations Amid Escalating Security Tensions in Israel
5M ago
42T
Trendlines Clears Related-Party Investments into Sol Chip and Celleste
Premium
Company Announcements
Trendlines Clears Related-Party Investments into Sol Chip and Celleste
5M ago
42T
Trendlines’ Phytolon Wins FDA Green Light for Natural Beetroot Red in U.S. Foods
PremiumCompany Announcements
Trendlines’ Phytolon Wins FDA Green Light for Natural Beetroot Red in U.S. Foods
6M ago
42T
Trendlines Bolsters Capital Base and Portfolio Momentum With New Placements and Leadership Moves
PremiumCompany Announcements
Trendlines Bolsters Capital Base and Portfolio Momentum With New Placements and Leadership Moves
6M ago
42T
Trendlines Finalises Transfer of Agrifood Fund Management to Proterra
PremiumCompany Announcements
Trendlines Finalises Transfer of Agrifood Fund Management to Proterra
6M ago
42T
Trendlines Group Completes S$0.067 Share Placement, Expanding Equity Base
PremiumCompany Announcements
Trendlines Group Completes S$0.067 Share Placement, Expanding Equity Base
7M ago
42T
Trendlines Group Wins SGX Nod for Placement of Up to 83.68 Million New Shares
PremiumCompany AnnouncementsTrendlines Group Wins SGX Nod for Placement of Up to 83.68 Million New Shares
7M ago
42T
Trendlines Group Plans S$5.6 Million Private Placement to Fund Portfolio Growth
Premium
Company Announcements
Trendlines Group Plans S$5.6 Million Private Placement to Fund Portfolio Growth
7M ago
42T
Trendlines Group Launches S$5.6 Million Share Placement at Discount
Premium
Company Announcements
Trendlines Group Launches S$5.6 Million Share Placement at Discount
7M ago
42T

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >